{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:50:48Z","timestamp":1780491048892,"version":"3.54.1"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007123","name":"Stanley Medical Research Institute","doi-asserted-by":"publisher","award":["07R-1888"],"award-info":[{"award-number":["07R-1888"]}],"id":[{"id":"10.13039\/100007123","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Geestkracht program of the Netherlands Organisation for Health Research and Development","award":["10-000-1002"],"award-info":[{"award-number":["10-000-1002"]}]}],"content-domain":{"domain":["journalofpsychiatricresearch.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.jpsychires.2016.08.020","type":"journal-article","created":{"date-parts":[[2016,9,8]],"date-time":"2016-09-08T19:50:33Z","timestamp":1473364233000},"page":"249-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Blood-based immune-endocrine biomarkers of treatment response in\u00a0depression"],"prefix":"10.1016","volume":"83","author":[{"given":"Man K.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariska","family":"Bot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom K.","family":"Birkenhager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerle","family":"Bergink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemmo A.","family":"Drexhage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Rothermundt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda W.J.H.","family":"Penninx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Bahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jpsychires.2016.08.020_bib1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0306-4530(98)00022-5","article-title":"Hormonal aspects of postpartum depression","volume":"23","author":"Abou-Saleh","year":"1998","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jpsychires.2016.08.020_bib2","series-title":"Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR","author":"API","year":"2000"},{"key":"10.1016\/j.jpsychires.2016.08.020_bib3","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1038\/tp.2011.63","article-title":"Plasma biomarkers of depressive symptoms in older adults","volume":"2","author":"Arnold","year":"2012","journal-title":"Transl. Psychiatry."},{"key":"10.1016\/j.jpsychires.2016.08.020_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jad.2013.10.019","article-title":"Pro-inflammatory cytokine associated with somatic and pain symptoms in depression","volume":"155","author":"Bai","year":"2014","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.jpsychires.2016.08.020_bib5","series-title":"Outliers in Statistical Data","author":"Barnett","year":"1978"},{"issue":"2","key":"10.1016\/j.jpsychires.2016.08.020_bib6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1600-0447.2009.01435.x","article-title":"The role of the inflammatory markers ferritin, transferrin and fibrinogen in the relationship between major depression and cardiovascular disorders - The German Health Interview and Examination Survey","volume":"121","author":"Baune","year":"2010","journal-title":"Acta Psychiatry Scand."},{"issue":"1","key":"10.1016\/j.jpsychires.2016.08.020_bib7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. Royal Stat. Soc. Series B (Methodological)"},{"key":"10.1016\/j.jpsychires.2016.08.020_bib8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1741-7015-11-200","article-title":"So depression is an inflammatory disease, but where does the inflammation come from?","volume":"11","author":"Berk","year":"2013","journal-title":"BMC Med"},{"issue":"5","key":"10.1016\/j.jpsychires.2016.08.020_bib9","first-page":"635","article-title":"Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. The Standards for Reporting of Diagnostic Accuracy Group","volume":"44","author":"Bossuyt","year":"2003","journal-title":"Croat. Med. J."},{"key":"10.1016\/j.jpsychires.2016.08.020_bib10","doi-asserted-by":"crossref","first-page":"e599","DOI":"10.1038\/tp.2015.88","article-title":"Serum proteomic profiling of major depressive disorder","volume":"5","author":"Bot","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpsychires.2016.08.020_bib11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jpsychires.2014.08.002","article-title":"Adipokines as emerging depression biomarkers: a systematic review and meta-analysis","volume":"59","author":"Carvalho","year":"2014","journal-title":"J. Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2016.08.020_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyw045","article-title":"Absolute measurements of macrophage migration inhibitory factor and interleukin-1-beta mrna levels accurately predict treatment response in depressed patients","author":"Cattaneo","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2016.08.020_bib13","article-title":"Identification of an immune-neuroendocrine biomarker panel for detection of depression: a joint effects statistical approach","author":"Chan","year":"2015","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jpsychires.2016.08.020_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pneurobio.2014.08.002","article-title":"Applications of blood-based protein biomarker strategies in the study of psychiatric disorders","volume":"122","author":"Chan","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jpsychires.2016.08.020_bib15","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1038\/tp.2015.91","article-title":"Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset","volume":"5","author":"Chan","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpsychires.2016.08.020_bib16","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jad.2013.10.004","article-title":"C-reactive protein and cortisol in drug-naive patients with short-illness-duration first episode major depressive disorder: possible role of cortisol immunomodulatory action at early stage of the disease","volume":"152-154","author":"Cubala","year":"2014","journal-title":"J. Affect Disord."},{"issue":"7","key":"10.1016\/j.jpsychires.2016.08.020_bib17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0306-4530(97)00046-2","article-title":"Insulin-like growth factor-I (IGF-I) plasma concentrations are increased in depressed patients","volume":"22","author":"Deuschle","year":"1997","journal-title":"Psychoneuroendocrinology"},{"issue":"10","key":"10.1016\/j.jpsychires.2016.08.020_bib18","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/gps.1592","article-title":"Elevation of plasma concentration of adhesion molecules in late-life depression","volume":"21","author":"Dimopoulos","year":"2006","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"4","key":"10.1016\/j.jpsychires.2016.08.020_bib19","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/npp.2011.285","article-title":"Cerebrospinal fluid biomarkers for major depression confirm relevance of associated pathophysiology","volume":"37","author":"Ditzen","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.jpsychires.2016.08.020_bib20","doi-asserted-by":"crossref","first-page":"e9166","DOI":"10.1371\/journal.pone.0009166","article-title":"Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections","volume":"5","author":"Domenici","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jpsychires.2016.08.020_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ajmg.b.30175","article-title":"Association of the apolipoprotein A-IV: 360 Gln\/His polymorphism with cerebrovascular disease, obesity, and depression in a Brazilian elderly population","volume":"135B","author":"Ejchel","year":"2005","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"issue":"1","key":"10.1016\/j.jpsychires.2016.08.020_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neulet.2010.10.003","article-title":"Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with different psychiatric disorders","volume":"487","author":"Emanuele","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"7","key":"10.1016\/j.jpsychires.2016.08.020_bib23","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.metabol.2005.02.006","article-title":"Younger, premenopausal women with major depressive disorder have more abdominal fat and increased serum levels of prothrombotic factors: implications for greater cardiovascular risk","volume":"54","author":"Eskandari","year":"2005","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.jpsychires.2016.08.020_bib24","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1176\/appi.ajp.2007.06111868","article-title":"Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report","volume":"165","author":"Fava","year":"2008","journal-title":"Am. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.jpsychires.2016.08.020_bib25","first-page":"645","article-title":"Fasting plasma peptide YY concentrations are increased in patients with major depression who associate weight loss","volume":"35","author":"Gimenez-Palop","year":"2012","journal-title":"J. Endocrinol. Invest."},{"issue":"1","key":"10.1016\/j.jpsychires.2016.08.020_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2012.04.072","article-title":"Unmedicated, remitted patients with major depression have decreased serum immunoglobulin A","volume":"520","author":"Gold","year":"2012","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.jpsychires.2016.08.020_bib27","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s40520-015-0504-3","article-title":"Plasma levels of thrombomodulin, plasminogen activator inhibitor-1 and fibrinogen in elderly, diabetic patients with depressive symptoms","volume":"28","author":"Gorska-Ciebiada","year":"2016","journal-title":"Aging Clin. Exp. Res."},{"issue":"9","key":"10.1016\/j.jpsychires.2016.08.020_bib28","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s00213-015-3943-9","article-title":"Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy","volume":"233","author":"Grosse","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.jpsychires.2016.08.020_bib29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/bmb\/ldv034","article-title":"Managing inadequate antidepressant response in depressive illness","volume":"115","author":"Haddad","year":"2015","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.jpsychires.2016.08.020_bib30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jad.2013.12.008","article-title":"Multiplex immunoassay analysis of plasma shows prominent upregulation of growth factor activity pathways linked to GSK3beta signaling in bipolar patients","volume":"156","author":"Haenisch","year":"2014","journal-title":"J. Affect Disord."},{"issue":"12","key":"10.1016\/j.jpsychires.2016.08.020_bib31","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1038\/npp.2011.132","article-title":"The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis","volume":"36","author":"Hannestad","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"1-3","key":"10.1016\/j.jpsychires.2016.08.020_bib32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jad.2012.11.008","article-title":"Recurrence of major depressive disorder across different treatment settings: results from the NESDA study","volume":"147","author":"Hardeveld","year":"2013","journal-title":"J. Affect Disord."},{"issue":"4","key":"10.1016\/j.jpsychires.2016.08.020_bib33","doi-asserted-by":"crossref","first-page":"7796","DOI":"10.3390\/ijms16047796","article-title":"Inflammatory biomarkers as differential predictors of antidepressant response","volume":"16","author":"Hashimoto","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.jpsychires.2016.08.020_bib34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/hup.1103","article-title":"A psychoneuroimmunological review on cytokines involved in antidepressant treatment response","volume":"25","author":"Janssen","year":"2010","journal-title":"Hum. Psychopharmacol."},{"issue":"2-3","key":"10.1016\/j.jpsychires.2016.08.020_bib35","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jad.2005.03.012","article-title":"Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity","volume":"87","author":"Kaestner","year":"2005","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.jpsychires.2016.08.020_bib36","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/1471-244X-14-164","article-title":"Lack of association of acute phase response proteins with hormone levels and antidepressant medication in perimenopausal depression","volume":"14","author":"Karaoulanis","year":"2014","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2016.08.020_bib37","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.psychres.2011.12.007","article-title":"Serum concentrations of CRP, IL-6, TNF-alpha and cortisol in major depressive disorder with melancholic or atypical features","volume":"198","author":"Karlovic","year":"2012","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.jpsychires.2016.08.020_bib38","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1176\/ajp.149.1.93","article-title":"Recovery and major depression: factors associated with twelve-month outcome","volume":"149","author":"Keitner","year":"1992","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2016.08.020_bib39","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neulet.2010.08.054","article-title":"Serum anti-inflammatory markers in general population subjects with elevated depressive symptoms","volume":"484","author":"Lehto","year":"2010","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.jpsychires.2016.08.020_bib40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1176\/appi.ajp.161.2.271","article-title":"The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes","volume":"161","author":"Lesperance","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.jpsychires.2016.08.020_bib41","doi-asserted-by":"crossref","first-page":"435","DOI":"10.31887\/DCNS.2009.11.4\/afleuchter","article-title":"A new paradigm for the prediction of antidepressant treatment response","volume":"11","author":"Leuchter","year":"2009","journal-title":"Dialogues Clin. Neurosci."},{"issue":"7","key":"10.1016\/j.jpsychires.2016.08.020_bib42","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.comppsych.2013.03.026","article-title":"Elevated specific peripheral cytokines found in major depressive disorder patients with childhood trauma exposure: a cytokine antibody array analysis","volume":"54","author":"Lu","year":"2013","journal-title":"Compr. Psychiatry"},{"issue":"11","key":"10.1016\/j.jpsychires.2016.08.020_bib43","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1006\/cyto.1997.0238","article-title":"Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression","volume":"9","author":"Maes","year":"1997","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.jpsychires.2016.08.020_bib44","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0278-5846(92)90056-K","article-title":"Disturbances in acute phase plasma proteins during melancholia: additional evidence for the presence of an inflammatory process during that illness","volume":"16","author":"Maes","year":"1992","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.jpsychires.2016.08.020_bib45","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0893-133X(98)00088-8","article-title":"Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion","volume":"20","author":"Maes","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"15","key":"10.1016\/j.jpsychires.2016.08.020_bib46","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1007\/s00213-014-3475-8","article-title":"High baseline BDNF serum levels and early psychopathological improvement are predictive of treatment outcome in major depression","volume":"231","author":"Mikoteit","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpsychires.2016.08.020_bib47","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.metabol.2012.08.021","article-title":"Personalized medicine in major depressive disorder \u2013 opportunities and pitfalls","author":"Miller","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.jpsychires.2016.08.020_bib48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.semcdb.2013.07.003","article-title":"Intercellular adhesion molecule 1: recent findings and new concepts involved in mammalian spermatogenesis","volume":"29","author":"Mruk","year":"2014","journal-title":"Semin. Cell Dev. Bio."},{"issue":"6","key":"10.1016\/j.jpsychires.2016.08.020_bib49","first-page":"2283","article-title":"Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy","volume":"31","author":"Nassiri","year":"2011","journal-title":"Anticancer Res."},{"issue":"7","key":"10.1016\/j.jpsychires.2016.08.020_bib50","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jpsychires.2013.03.011","article-title":"Newly diagnosed depression is associated with increased beta-thromboglobulin levels and increased expression of platelet activation markers and platelet derived CD40-CD40L","volume":"47","author":"Neubauer","year":"2013","journal-title":"J. Psychiatry Res."},{"key":"10.1016\/j.jpsychires.2016.08.020_bib51","series-title":"Depression: The Treatment and Management of Depression in Adults (Updated Edition)","author":"NICE","year":"2010"},{"issue":"10","key":"10.1016\/j.jpsychires.2016.08.020_bib52","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1053\/meta.2000.9515","article-title":"Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis","volume":"49","author":"Okamura","year":"2000","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.jpsychires.2016.08.020_bib53","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1176\/appi.ajp.163.1.101","article-title":"Continuity of antidepressant treatment for adults with depression in the United States","volume":"163","author":"Olfson","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.jpsychires.2016.08.020_bib54","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1073\/pnas.1318786111","article-title":"Elevated morning cortisol is a stratified population-level biomarker for major depression in boys only with high depressive symptoms","volume":"111","author":"Owens","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"6","key":"10.1016\/j.jpsychires.2016.08.020_bib55","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1017\/S1461145711001246","article-title":"Surrogate markers of treatment outcome in major depressive disorder","volume":"15","author":"Papakostas","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.jpsychires.2016.08.020_bib56","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.euroneuro.2008.08.009","article-title":"Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD","volume":"19","author":"Papakostas","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.jpsychires.2016.08.020_bib57","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/mp.2011.166","article-title":"Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study","volume":"18","author":"Papakostas","year":"2013","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2016.08.020_bib58","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/mpr.256","article-title":"The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods","volume":"17","author":"Penninx","year":"2008","journal-title":"Int. J. Methods Psychiatry Res."},{"issue":"2","key":"10.1016\/j.jpsychires.2016.08.020_bib59","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1176\/appi.ajp.2014.14010076","article-title":"Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches","volume":"172","author":"Phillips","year":"2015","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2016.08.020_bib60","doi-asserted-by":"crossref","first-page":"e91076","DOI":"10.1371\/journal.pone.0091076","article-title":"Putative transcriptomic biomarkers in the inflammatory cytokine pathway differentiate major depressive disorder patients from control subjects and bipolar disorder patients","volume":"9","author":"Powell","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jpsychires.2016.08.020_bib61","series-title":"R: A language and environment for statistical computing","author":"RCoreTeam","year":"2013"},{"key":"10.1016\/j.jpsychires.2016.08.020_bib62","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.psyneuen.2014.10.005","article-title":"Hypothalamic-pituitary-adrenal axis activity in older persons with and without a depressive disorder","volume":"51","author":"Rhebergen","year":"2015","journal-title":"Psychoneuroendocrinology"},{"issue":"1-3","key":"10.1016\/j.jpsychires.2016.08.020_bib63","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-0327(00)00157-9","article-title":"Inflammatory markers in major depression and melancholia","volume":"63","author":"Rothermundt","year":"2001","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.jpsychires.2016.08.020_bib64","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1017\/S0033291700035558","article-title":"The Inventory of Depressive Symptomatology (IDS): psychometric properties","volume":"26","author":"Rush","year":"1996","journal-title":"Psychol. Med."},{"issue":"8","key":"10.1016\/j.jpsychires.2016.08.020_bib65","first-page":"627","article-title":"STAR*D: revising conventional wisdom","volume":"23","author":"Rush","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpsychires.2016.08.020_bib66","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4137\/BMI.S5183","article-title":"Decreased Serum Hepatocyte Growth Factor (HGF) in individuals with depression correlates with severity of disease","volume":"5","author":"Russo","year":"2010","journal-title":"Biomark Insights"},{"issue":"6","key":"10.1016\/j.jpsychires.2016.08.020_bib67","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1365-3083.1995.tb03604.x","article-title":"Cytokine production and serum proteins in depression","volume":"41","author":"Seidel","year":"1995","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jpsychires.2016.08.020_bib68","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pnpbp.2012.10.021","article-title":"Phosphorylation of leukocyte glucocorticoid receptor in patients with current episode of major depressive disorder","volume":"40","author":"Simic","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2016.08.020_bib69","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.euroneuro.2007.06.004","article-title":"A detailed examination of cytokine abnormalities in major depressive disorder","volume":"18","author":"Simon","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.jpsychires.2016.08.020_bib70","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1388-1981(03)00004-0","article-title":"Apo A-IV: an update on regulation and physiologic functions","volume":"1631","author":"Stan","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.jpsychires.2016.08.020_bib71","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1017\/S1461145714000819","article-title":"Proteomic changes in serum of first onset, antidepressant drug-naive major depression patients","volume":"17","author":"Stelzhammer","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.jpsychires.2016.08.020_bib72","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/PSY.0b013e31820ad12b","article-title":"Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research","volume":"73","author":"Stetler","year":"2011","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.jpsychires.2016.08.020_bib73","series-title":"Texas Medication Algorithm Project Procedural Manual: Major Depressive Disorder Algorithms","author":"Suehs","year":"2008"},{"key":"10.1016\/j.jpsychires.2016.08.020_bib74","series-title":"The Maudsley Prescribing Guidelines in Psychiatry","author":"Taylor","year":"2015"},{"issue":"10","key":"10.1016\/j.jpsychires.2016.08.020_bib75","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1176\/appi.ajp.157.10.1682","article-title":"Elevation in late-life depression of intercellular adhesion molecule-1 expression in the dorsolateral prefrontal cortex","volume":"157","author":"Thomas","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.jpsychires.2016.08.020_bib76","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/FPC.0b013e328308bbc0","article-title":"Plasminogen activator inhibitor-1 gene is associated with major depression and antidepressant treatment response","volume":"18","author":"Tsai","year":"2008","journal-title":"Pharmacogenet. Genom."},{"issue":"8","key":"10.1016\/j.jpsychires.2016.08.020_bib77","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.4088\/JCP.12r07694","article-title":"Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis","volume":"73","author":"Udina","year":"2012","journal-title":"J. Clin. Psychiatry"},{"issue":"12","key":"10.1016\/j.jpsychires.2016.08.020_bib78","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1176\/appi.ajp.2014.14010094","article-title":"An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline","volume":"171","author":"Uher","year":"2014","journal-title":"Am. J. Psychiatry"},{"issue":"Database issue","key":"10.1016\/j.jpsychires.2016.08.020_bib79","first-page":"D204","article-title":"UniProt: a hub for protein information","volume":"43","author":"UniProt, C","year":"2015","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.jpsychires.2016.08.020_bib80","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jpsychires.2013.05.029","article-title":"A double-blind randomized study comparing plasma level-targeted dose imipramine and high-dose venlafaxine in depressed inpatients","volume":"47","author":"Vermeiden","year":"2013","journal-title":"J. Psychiatry Res."},{"issue":"1","key":"10.1016\/j.jpsychires.2016.08.020_bib81","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-0028-1085442","article-title":"Insulin-like growth factor-I (IGF-I) serum concentrations in depressed patients: relationship to saliva cortisol and changes during antidepressant treatment","volume":"42","author":"Weber-Hamann","year":"2009","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2016.08.020_bib82","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1073\/pnas.97.1.325","article-title":"Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone","volume":"97","author":"Wong","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"5","key":"10.1016\/j.jpsychires.2016.08.020_bib83","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.eurpsy.2014.03.004","article-title":"Plasma-based proteomics reveals lipid metabolic and immunoregulatory dysregulation in post-stroke depression","volume":"29","author":"Zhan","year":"2014","journal-title":"Eur. Psychiatry"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395616302977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395616302977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T19:40:05Z","timestamp":1657222805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395616302977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":83,"alternative-id":["S0022395616302977"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2016.08.020","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood-based immune-endocrine biomarkers of treatment response in\u00a0depression","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2016.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}